Alzheimer disease: who works on it

One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.

• All targets
• APOE 16
• MAPT 2
• APP 1
• NRF2 0
• NLRP3 0
• TREM2 0
• AKT 0
• TDP-43 2
• BDNF 0
• PI3K 0
• BACE1 0
• GLP-1 1
• MAPK 0
• PPAR 0
• AMPK 0
• mTOR 0
• PSEN1 1
• STING 0
• ERK 0
• NMDA 1
• SNCA 0
• TLR4 0
• JNK 0
• SIRT1 0
• CTNNB1 0
• STAT3 0
• TP53 0
• TNF 0
• HDAC 0
• HIF-1 0
• SGLT2 0
• HMGB1 0
• GPX4 0
• IL-1 0
• PCSK9 0
• COX-2 0
• HSP90 1
• C9orf72 0
• DPP-4 0
• PINK1 0
• IL-17 0
• TFEB 0
• IL-6 0
• PD-L1 0
• VEGF 0
• YAP 0
• AQP4 0
• CD33 0
• IGF1R 0
• MMP-9 0
• CCR5 0
• EGFR 0
• FTO 0
• GBA1 0
• GIP 0
• JAK 0
• KEAP1 0
• PARP 0
• PD-1 0
• ACE2 0

EU-13 is a filter, not a ranking: it only narrows the list.

2 of 2+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Trials whose registry record says individual participant data (IPD) will be shared.

• Study to Understand Novel Biomarkers in Researching Dementia

  NCT06547099· Washington University School of Medicine· Source

• Synaptic density and tau pathology in Alzheimer’s disease

  2024-517636-22-00· Amsterdam UMC Stichting· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 86
• Organoids 36
• Mendelian Randomization Analysis 136
• CRISPR-Cas Systems 24
• Gene Expression Profiling 175
• Sequence Analysis, RNA 20
• Whole Genome Sequencing 17
• Exome Sequencing 7
• Proteomics 228
• Metabolomics 81
• Mass Spectrometry 62
• Flow Cytometry 16
• Immunohistochemistry 74
• Liquid Biopsy 5
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 672
• Magnetic Resonance Imaging 992
• Machine Learning 253
• Deep Learning 166
• Cohort Studies 533
• Genome-Wide Association Study 215

• Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

  Methods Mol Biol, Jan 2027

• Single-cell machine learning uncovers genetically anchored, cell-type specific programs of Alzheimer's disease.

  Nat Commun, Nov 2026

• Transcriptomic signature of frontotemporal lobar degeneration with TDP-43 type C pathology.

  Brain, Nov 2026

• Attentive interpretable tabular learning (TabNet) for miRNA expression classification in cervical cancer and Alzheimer's disease.

  BMC Bioinformatics, Oct 2026

• L1CAM-Enriched Extracellular Vesicle MicroRNAs in Mild Cognitive Impairment and Alzheimer's Disease: An Exploratory Study.

  Int J Mol Sci, Oct 2026

• Identification of Succinylation-Related Transcriptional Signatures in Alzheimer's Disease: Integrated Bioinformatics Analysis and Clinical Validation.

  Mol Neurobiol, Oct 2026

• Integrative Genetic and Transcriptomic Analysis Reveals Candidate Molecular Differences Among Dementia with Lewy Bodies, Alzheimer's Disease, and Parkinson's Disease Dementia.

  Int J Mol Sci, Oct 2026

• Multi-Cohort Transcriptomic Integration Identifies Overlapping Immune and Antigen-Presentation Features in Alzheimer's Disease and Hashimoto's Thyroiditis.

  Genes (Basel), Oct 2026

• Integrative Transcriptomic and Interactome Analyses Prioritize Candidate Genes for Alzheimer's Disease.

  Mol Neurobiol, Oct 2026

• Multi-Scale Integrative Transcriptomic Analysis of Alzheimer's Disease and Atopic Dermatitis Reveals Shared Immune and Cellular Networks.

  Am J Alzheimers Dis Other Demen, Oct 2026

See which targets of this disease your abstract mentions, and go to the people working on them.